Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes

Jia Ying Sung, Susanna B. Park, Ya Ting Liu, Natalie Kwai, Ria Arnold, Arun V. Krishnan, Cindy S Y Lin

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

To evaluate the development of diabetic neuropathy, the current study examined changes in peripheral axonal function. Nerve excitability techniques were undertaken in 108 type 2 diabetic patients with nerve conduction studies (NCS), HbA1c levels, and total neuropathy score (TNS). Patients were categorized into two cohorts: patients with diabetes without neuropathy (DWN group [n = 56]) and patients with diabetes with neuropathy (DN group [n = 52]) and further into severity grade 0 (TNS 0-1 [n = 35]), grade 1 (TNS 2-8 [n = 42]), and grade 2/3 (TNS 9-24 [n = 31]). Results revealed that the DWN group had a significantly increased threshold, prolonged latency, and changes in excitability parameters compared with age-matched control subjects. Patients with neuropathy demonstrated significant alteration in recovery cycle parameters and depolarizing threshold electrotonus. Within the DWN cohort, there were significant correlations between HbA 1clevel and latency and subexcitability, whereas the estimated glomerular filtration rate correlated with superexcitability in patients with neuropathy. Furthermore, excitability parameters became progressively more abnormal with increasing clinical severity. These results suggest a spectrum of excitability abnormalities in patients with diabetes and that early axonal dysfunction may be detected prior to the development of neuropathy. As progressive changes in excitability parameters correlated to neuropathy severity, excitability testing may provide a biomarker of the early development and severity of diabetic neuropathy, providing insights into the pathophysiological mechanisms producing axonal dysfunction.

Original languageEnglish
Pages (from-to)1592-1598
Number of pages7
JournalDiabetes
Volume61
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Type 2 Diabetes Mellitus
Diabetic Neuropathies
Neural Conduction
Glomerular Filtration Rate
Biomarkers

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Sung, J. Y., Park, S. B., Liu, Y. T., Kwai, N., Arnold, R., Krishnan, A. V., & Lin, C. S. Y. (2012). Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes, 61(6), 1592-1598. https://doi.org/10.2337/db11-1509

Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. / Sung, Jia Ying; Park, Susanna B.; Liu, Ya Ting; Kwai, Natalie; Arnold, Ria; Krishnan, Arun V.; Lin, Cindy S Y.

In: Diabetes, Vol. 61, No. 6, 06.2012, p. 1592-1598.

Research output: Contribution to journalArticle

Sung, JY, Park, SB, Liu, YT, Kwai, N, Arnold, R, Krishnan, AV & Lin, CSY 2012, 'Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes', Diabetes, vol. 61, no. 6, pp. 1592-1598. https://doi.org/10.2337/db11-1509
Sung, Jia Ying ; Park, Susanna B. ; Liu, Ya Ting ; Kwai, Natalie ; Arnold, Ria ; Krishnan, Arun V. ; Lin, Cindy S Y. / Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. In: Diabetes. 2012 ; Vol. 61, No. 6. pp. 1592-1598.
@article{af7798715f184477b176a4c636255fd9,
title = "Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes",
abstract = "To evaluate the development of diabetic neuropathy, the current study examined changes in peripheral axonal function. Nerve excitability techniques were undertaken in 108 type 2 diabetic patients with nerve conduction studies (NCS), HbA1c levels, and total neuropathy score (TNS). Patients were categorized into two cohorts: patients with diabetes without neuropathy (DWN group [n = 56]) and patients with diabetes with neuropathy (DN group [n = 52]) and further into severity grade 0 (TNS 0-1 [n = 35]), grade 1 (TNS 2-8 [n = 42]), and grade 2/3 (TNS 9-24 [n = 31]). Results revealed that the DWN group had a significantly increased threshold, prolonged latency, and changes in excitability parameters compared with age-matched control subjects. Patients with neuropathy demonstrated significant alteration in recovery cycle parameters and depolarizing threshold electrotonus. Within the DWN cohort, there were significant correlations between HbA 1clevel and latency and subexcitability, whereas the estimated glomerular filtration rate correlated with superexcitability in patients with neuropathy. Furthermore, excitability parameters became progressively more abnormal with increasing clinical severity. These results suggest a spectrum of excitability abnormalities in patients with diabetes and that early axonal dysfunction may be detected prior to the development of neuropathy. As progressive changes in excitability parameters correlated to neuropathy severity, excitability testing may provide a biomarker of the early development and severity of diabetic neuropathy, providing insights into the pathophysiological mechanisms producing axonal dysfunction.",
author = "Sung, {Jia Ying} and Park, {Susanna B.} and Liu, {Ya Ting} and Natalie Kwai and Ria Arnold and Krishnan, {Arun V.} and Lin, {Cindy S Y}",
year = "2012",
month = "6",
doi = "10.2337/db11-1509",
language = "English",
volume = "61",
pages = "1592--1598",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes

AU - Sung, Jia Ying

AU - Park, Susanna B.

AU - Liu, Ya Ting

AU - Kwai, Natalie

AU - Arnold, Ria

AU - Krishnan, Arun V.

AU - Lin, Cindy S Y

PY - 2012/6

Y1 - 2012/6

N2 - To evaluate the development of diabetic neuropathy, the current study examined changes in peripheral axonal function. Nerve excitability techniques were undertaken in 108 type 2 diabetic patients with nerve conduction studies (NCS), HbA1c levels, and total neuropathy score (TNS). Patients were categorized into two cohorts: patients with diabetes without neuropathy (DWN group [n = 56]) and patients with diabetes with neuropathy (DN group [n = 52]) and further into severity grade 0 (TNS 0-1 [n = 35]), grade 1 (TNS 2-8 [n = 42]), and grade 2/3 (TNS 9-24 [n = 31]). Results revealed that the DWN group had a significantly increased threshold, prolonged latency, and changes in excitability parameters compared with age-matched control subjects. Patients with neuropathy demonstrated significant alteration in recovery cycle parameters and depolarizing threshold electrotonus. Within the DWN cohort, there were significant correlations between HbA 1clevel and latency and subexcitability, whereas the estimated glomerular filtration rate correlated with superexcitability in patients with neuropathy. Furthermore, excitability parameters became progressively more abnormal with increasing clinical severity. These results suggest a spectrum of excitability abnormalities in patients with diabetes and that early axonal dysfunction may be detected prior to the development of neuropathy. As progressive changes in excitability parameters correlated to neuropathy severity, excitability testing may provide a biomarker of the early development and severity of diabetic neuropathy, providing insights into the pathophysiological mechanisms producing axonal dysfunction.

AB - To evaluate the development of diabetic neuropathy, the current study examined changes in peripheral axonal function. Nerve excitability techniques were undertaken in 108 type 2 diabetic patients with nerve conduction studies (NCS), HbA1c levels, and total neuropathy score (TNS). Patients were categorized into two cohorts: patients with diabetes without neuropathy (DWN group [n = 56]) and patients with diabetes with neuropathy (DN group [n = 52]) and further into severity grade 0 (TNS 0-1 [n = 35]), grade 1 (TNS 2-8 [n = 42]), and grade 2/3 (TNS 9-24 [n = 31]). Results revealed that the DWN group had a significantly increased threshold, prolonged latency, and changes in excitability parameters compared with age-matched control subjects. Patients with neuropathy demonstrated significant alteration in recovery cycle parameters and depolarizing threshold electrotonus. Within the DWN cohort, there were significant correlations between HbA 1clevel and latency and subexcitability, whereas the estimated glomerular filtration rate correlated with superexcitability in patients with neuropathy. Furthermore, excitability parameters became progressively more abnormal with increasing clinical severity. These results suggest a spectrum of excitability abnormalities in patients with diabetes and that early axonal dysfunction may be detected prior to the development of neuropathy. As progressive changes in excitability parameters correlated to neuropathy severity, excitability testing may provide a biomarker of the early development and severity of diabetic neuropathy, providing insights into the pathophysiological mechanisms producing axonal dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=84861884883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861884883&partnerID=8YFLogxK

U2 - 10.2337/db11-1509

DO - 10.2337/db11-1509

M3 - Article

C2 - 22522615

AN - SCOPUS:84861884883

VL - 61

SP - 1592

EP - 1598

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -